AAAAAA

   
Results: 1-25 | 26-50 | 51-55
Results: 1-25/55
SPLENECTOMY AND RISK OF BLAST-TRANSFORMATION IN MYELOFIBROSIS WITH MYELOID METAPLASIA
Authors: BAROSI G AMBROSETTI A CENTRA A FALCONE A FINELLI C FOA P GROSSI A GUARNONE R RUPOLI S LUCIANO L PETTI MC POGLIANI E RUSSO D RUGGERI M QUAGLINI S
Citation: G. Barosi et al., SPLENECTOMY AND RISK OF BLAST-TRANSFORMATION IN MYELOFIBROSIS WITH MYELOID METAPLASIA, Blood, 91(10), 1998, pp. 3630-3636
POLYCYTHEMIA-VERA TREATED WITH PIPOBROMAN AS SINGLE-AGENT - LOW INCIDENCE OF SECONDARY LEUKEMIA IN A COHORT OF PATIENTS OBSERVED DURING 20 YEARS (1971-1991)
Authors: PETTI MC SPADEA A AVVISATI G SPADEA T LATAGLIATA R MONTEFUSCO E COSENZA M MALAGNINO F
Citation: Mc. Petti et al., POLYCYTHEMIA-VERA TREATED WITH PIPOBROMAN AS SINGLE-AGENT - LOW INCIDENCE OF SECONDARY LEUKEMIA IN A COHORT OF PATIENTS OBSERVED DURING 20 YEARS (1971-1991), Leukemia, 12(6), 1998, pp. 869-874
FLUDARABINE, CYTARABINE, AND G-CSF (FLAG) FOR THE TREATMENT OF POOR-RISK ACUTE MYELOID-LEUKEMIA
Authors: MONTILLO M MIRTO S PETTI MC LATAGLIATA R MAGRIN S PINTO A ZAGONEL V MELE G TEDESCHI A FERRARA F
Citation: M. Montillo et al., FLUDARABINE, CYTARABINE, AND G-CSF (FLAG) FOR THE TREATMENT OF POOR-RISK ACUTE MYELOID-LEUKEMIA, American journal of hematology, 58(2), 1998, pp. 105-109
A SYSTEMATIC COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS COMPARING IDARUBICIN WITH DAUNORUBICIN (OR OTHER ANTHRACYCLINES) AS INDUCTION THERAPY FOR ACUTE MYELOID-LEUKEMIA
Authors: WHEATLEY D DUTCHER JP WIERNIK PH HUGUET F POLIN V REIFFERS J SOTTO JJ STOPPA AM MANDELLI F PETTI MC HAROUSSEAU JL MERCIER M POLIN V TELLIER Z BERMAN E STAGG M VOGLER WR BEZWODA WR ALISON R CLARKE M EVANS V GRAY R GREAVES E HALL E HICKS C JAMES S PETO R RICHARDS S SINCLAIR D TOOTH A WHEATLEY K
Citation: D. Wheatley et al., A SYSTEMATIC COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS COMPARING IDARUBICIN WITH DAUNORUBICIN (OR OTHER ANTHRACYCLINES) AS INDUCTION THERAPY FOR ACUTE MYELOID-LEUKEMIA, British Journal of Haematology, 103(1), 1998, pp. 100-109
THE INFLUENCE OF HLA-MATCHED SIBLING DONOR AVAILABILITY ON TREATMENT OUTCOME FOR PATIENTS WITH AML - AN ANALYSIS OF THE AML 8A STUDY OF THEEORTC-LEUKEMIA-COOPERATIVE-GROUP AND GIMEMA
Authors: KEATING S DEWITTE T SUCIU S WILLEMZE R HAYAT M LABAR B RESEGOTTI L FERRINI PR CARONIA F DARDENNE M SOLBU G PETTI MC VEGNA ML MANDELLI F ZITTOUN RA
Citation: S. Keating et al., THE INFLUENCE OF HLA-MATCHED SIBLING DONOR AVAILABILITY ON TREATMENT OUTCOME FOR PATIENTS WITH AML - AN ANALYSIS OF THE AML 8A STUDY OF THEEORTC-LEUKEMIA-COOPERATIVE-GROUP AND GIMEMA, British Journal of Haematology, 102(5), 1998, pp. 1344-1353
THERAPY OF MINIMAL DISEASE RECURRENCE IN ACUTE PROMYELOCYTIC LEUKEMIA
Authors: LOCOCO F DIVERIO D PETTI MC AVVISATI G POGLIANI EM BIONDI A MELONI G MANDELLI F
Citation: F. Lococo et al., THERAPY OF MINIMAL DISEASE RECURRENCE IN ACUTE PROMYELOCYTIC LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 149-149
HIGH-DOSE HYDROXYUREA (HIGH-HY) IN THE TREATMENT OF POOR-RISK ACUTE MYELOID-LEUKEMIA
Authors: PETTI MC SPIRITI MAA MONTEFUSCO E REDI R MANCINI M COMANDINI A DELIA GM MANDELLI F
Citation: Mc. Petti et al., HIGH-DOSE HYDROXYUREA (HIGH-HY) IN THE TREATMENT OF POOR-RISK ACUTE MYELOID-LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 222-222
ACUTE PROMYELOCYTIC LEUKEMIA (APL) IN THE ELDERLY - RESULTS OF THE AIDA PROTOCOL
Authors: PETTI MC
Citation: Mc. Petti, ACUTE PROMYELOCYTIC LEUKEMIA (APL) IN THE ELDERLY - RESULTS OF THE AIDA PROTOCOL, British Journal of Haematology, 102(1), 1998, pp. 226-226
HIGH-LEVELS OF APOPTOSIS CHARACTERIZE RAEB AND ARE LOST DURING LEUKEMIC TRANSFORMATION
Authors: RICCIARDI MR PETRUCCI MT ARIOLA C GREGORJ C LATAGLIATA R PETTI MC TAFURI A
Citation: Mr. Ricciardi et al., HIGH-LEVELS OF APOPTOSIS CHARACTERIZE RAEB AND ARE LOST DURING LEUKEMIC TRANSFORMATION, British Journal of Haematology, 102(1), 1998, pp. 282-282
EARLY DETECTION OF RELAPSE BY PROSPECTIVE REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION ANALYSIS OF THE PML RAR-ALPHA FUSION GENE IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA ENROLLED IN THE GIMEMA-AIEOP MULTICENTER AIDA TRIAL/
Authors: DIVERIO D ROSSI V AVVISATI G DESANTIS S PISTILLI A PANE F SAGLIO G MARTINELLI G PETTI MC SANTORO A PELICCI PG MANDELLI F BIONDI A LOCOCO F
Citation: D. Diverio et al., EARLY DETECTION OF RELAPSE BY PROSPECTIVE REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION ANALYSIS OF THE PML RAR-ALPHA FUSION GENE IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA ENROLLED IN THE GIMEMA-AIEOP MULTICENTER AIDA TRIAL/, Blood, 92(3), 1998, pp. 784-789
BCR-ABL ANTISENSE OLIGODEOXYNUCLEOTIDE IN-VITRO PURGING AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN ADVANCED PHASE
Authors: DEFABRITIIS P PETTI MC MONTEFUSCO E DEPROPRIS MS SALA R BELLUCCI R MANCINI M LISCI A BONETTO F GEISER T CALABRETTA B MANDELLI F
Citation: P. Defabritiis et al., BCR-ABL ANTISENSE OLIGODEOXYNUCLEOTIDE IN-VITRO PURGING AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN ADVANCED PHASE, Blood, 91(9), 1998, pp. 3156-3162
NEW TRENDS IN THE TREATMENT OF ADULT ACUTE MYELOID-LEUKEMIA
Authors: WILLEMZE R SUCIU S MANDELLI F DEWITTE T AMADORI S HAYAT M PETTI MC SOLBU G ZITTOUN R
Citation: R. Willemze et al., NEW TRENDS IN THE TREATMENT OF ADULT ACUTE MYELOID-LEUKEMIA, European journal of cancer, 33, 1997, pp. 7-14
ORAL GLUTAMINE IN THE PREVENTION OF CHEMOTHERAPY-INDUCED GASTROINTESTINAL TOXICITY
Authors: MUSCARITOLI M MICOZZI A CONVERSANO L MARTINO P PETTI MC CARTONI C CASCINO A ROSSIFANELLI F
Citation: M. Muscaritoli et al., ORAL GLUTAMINE IN THE PREVENTION OF CHEMOTHERAPY-INDUCED GASTROINTESTINAL TOXICITY, European journal of cancer, 33(2), 1997, pp. 319-320
ETOPOSIDE, INTERMEDIATE-DOSE CYTARABINE AND CARBOPLATIN (VAC) - A COMBINATION THERAPY FOR THE BLASTIC PHASE OF CHRONIC MYELOGENOUS LEUKEMIA
Authors: MONTEFUSCO E PETTI MC ALIMENA G LATAGLIATA R CELESTI F CAPRIA S AMADORI S AVVISATI G MANDELLI F
Citation: E. Montefusco et al., ETOPOSIDE, INTERMEDIATE-DOSE CYTARABINE AND CARBOPLATIN (VAC) - A COMBINATION THERAPY FOR THE BLASTIC PHASE OF CHRONIC MYELOGENOUS LEUKEMIA, Annals of oncology, 8(2), 1997, pp. 175-179
THE ROLE OF ALL-TRANS-RETINOIC ACID (ATRA) TREATMENT IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA PATIENTS AGED GREATER-THAN-60 YEARS
Authors: LATAGLIATA R AVVISATI G LOCOCO F PETTI MC DIVERIO D SPADEA A FAZI P TORROMEO C BRECCIA M MALAGNINO F MANDELLI F
Citation: R. Latagliata et al., THE ROLE OF ALL-TRANS-RETINOIC ACID (ATRA) TREATMENT IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA PATIENTS AGED GREATER-THAN-60 YEARS, Annals of oncology, 8(12), 1997, pp. 1273-1275
CYTOREDUCTIVE THERAPY OF ESSENTIAL THROMBOCYTHEMIA - PROPOSAL OF A SCORE SYSTEM
Authors: SPADEA A PERAINO M BERNASCONI S LATAGLIATA R PETTI MC MAZZUCCONI MG
Citation: A. Spadea et al., CYTOREDUCTIVE THERAPY OF ESSENTIAL THROMBOCYTHEMIA - PROPOSAL OF A SCORE SYSTEM, Thrombosis and haemostasis, 1997, pp. 181-181
MOLECULAR REMISSION IN PML RAR-ALPHA-POSITIVE ACUTE PROMYELOCYTIC LEUKEMIA BY COMBINED ALL-TRANS-RETINOIC ACID AND IDARUBICIN (AIDA) THERAPY/
Authors: MANDELLI F DIVERIO D AVVISATI G LUCIANO A BARBUI T BERNASCONI C BROCCIA G CERRI R FALDA M FIORITONI G LEONI F LISO V PETTI MC RODEGHIERO F SAGLIO G VEGNA ML VISANI G JEHN U WILLEMZE R MUUS P PELICCI PG BIONDI A LOCOCO F
Citation: F. Mandelli et al., MOLECULAR REMISSION IN PML RAR-ALPHA-POSITIVE ACUTE PROMYELOCYTIC LEUKEMIA BY COMBINED ALL-TRANS-RETINOIC ACID AND IDARUBICIN (AIDA) THERAPY/, Blood, 90(3), 1997, pp. 1014-1021
AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE PROMYELOCYTIC LEUKEMIA IN 2ND REMISSION - PROGNOSTIC RELEVANCE OF PRETRANSPLANT MINIMAL RESIDUAL DISEASE ASSESSMENT BY REVERSE-TRANSCRIPTION POLYMERASE CHAIN-REACTION OF THE PML RAR-ALPHA FUSION GENE/
Authors: MELONI G DIVERIO D VIGNETTI M AVVISATI G CAPRIA S PETTI MC MANDELLI F LOCOCO F
Citation: G. Meloni et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE PROMYELOCYTIC LEUKEMIA IN 2ND REMISSION - PROGNOSTIC RELEVANCE OF PRETRANSPLANT MINIMAL RESIDUAL DISEASE ASSESSMENT BY REVERSE-TRANSCRIPTION POLYMERASE CHAIN-REACTION OF THE PML RAR-ALPHA FUSION GENE/, Blood, 90(3), 1997, pp. 1321-1325
MULTIDRUG-RESISTANCE (MDR1) IN YOUNGER ADULT DE-NOVO ACUTE MYELOID-LEUKEMIA PATIENTS - LOW-FREQUENCY OF EXPRESSION AND LARK OF UNFAVORABLE PROGNOSTIC VALUE
Authors: ARIOLA C PETRUCCI MT RICCIARDI MR GREGORJ C BRECCIA M DECUIA R VEGNA ML PETTI MC TAFURI A
Citation: C. Ariola et al., MULTIDRUG-RESISTANCE (MDR1) IN YOUNGER ADULT DE-NOVO ACUTE MYELOID-LEUKEMIA PATIENTS - LOW-FREQUENCY OF EXPRESSION AND LARK OF UNFAVORABLE PROGNOSTIC VALUE, Blood, 90(10), 1997, pp. 798-798
AUTOLOGOUS BONE-MARROW TRANSPLANTATION AFTER IN-VITRO TREATMENT WITH BCR-ABL ANTISENSE OLIGODEOXYNUCLEOTIDES FOR PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN ADVANCED PHASE
Authors: DEFABRITIIS P PETTI MC MONTEFUSCO E DEPROPRIS M BELLUCCI R MANCINI M LISCI A CALLABRETA B MANDELLI F
Citation: P. Defabritiis et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION AFTER IN-VITRO TREATMENT WITH BCR-ABL ANTISENSE OLIGODEOXYNUCLEOTIDES FOR PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN ADVANCED PHASE, Blood, 90(10), 1997, pp. 1875-1875
HIGH-LEVELS OF APOPTOSIS CHARACTERIZE RAEB AND ARE LOST DURING LEUKEMIC TRANSFORMATION
Authors: RICCIARDI MR PETRUCCI MT ARIOLA C GREGORJ C MAZZOLA F LATAGLIATA R PETTI MC TAFURI A
Citation: Mr. Ricciardi et al., HIGH-LEVELS OF APOPTOSIS CHARACTERIZE RAEB AND ARE LOST DURING LEUKEMIC TRANSFORMATION, Blood, 90(10), 1997, pp. 2317-2317
PROBABILITY OF LONG-TERM DISEASE-FREE SURVIVAL FOR ACUTE MYELOID-LEUKEMIA PATIENTS AFTER FIRST RELAPSE - A SINGLE-CENTER EXPERIENCE
Authors: VIGNETTI M ORSINI E PETTI MC MOLETI ML ANDRIZZI C PINTO RM AMADORI S MELONI G
Citation: M. Vignetti et al., PROBABILITY OF LONG-TERM DISEASE-FREE SURVIVAL FOR ACUTE MYELOID-LEUKEMIA PATIENTS AFTER FIRST RELAPSE - A SINGLE-CENTER EXPERIENCE, Annals of oncology, 7(9), 1996, pp. 933-938
OUTCOME OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA WHO FAILED TO RESPONDTO A SINGLE COURSE OF FIRST-LINE INDUCTION THERAPY - A GIMEMA STUDY OF 218 UNSELECTED CONSECUTIVE PATIENTS
Authors: LISO V IACOPINO P AVVISATI G PETTI MC BROCCIA G CAROTENUTO M FALDA M FAZI P LAZZARINO M LEONI P MIRTO S PUCCI G NOBILE F NOSARI AM SPECCHIA G STASI R TABILIO A MANDELLI F
Citation: V. Liso et al., OUTCOME OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA WHO FAILED TO RESPONDTO A SINGLE COURSE OF FIRST-LINE INDUCTION THERAPY - A GIMEMA STUDY OF 218 UNSELECTED CONSECUTIVE PATIENTS, Leukemia, 10(9), 1996, pp. 1443-1452
A PHASE-II STUDY OF VP-16, INTERMEDIATE-DOSE ARA-C AND CARBOPLATIN (VAC) IN ADVANCED ACUTE MYELOGENOUS LEUKEMIA AND BLASTIC CHRONIC MYELOGENOUS LEUKEMIA
Authors: AMADORI S PICARDI A FAZI P TESTI AM PETTI MC MONTEFUSCO E MANDELLI F
Citation: S. Amadori et al., A PHASE-II STUDY OF VP-16, INTERMEDIATE-DOSE ARA-C AND CARBOPLATIN (VAC) IN ADVANCED ACUTE MYELOGENOUS LEUKEMIA AND BLASTIC CHRONIC MYELOGENOUS LEUKEMIA, Leukemia, 10(5), 1996, pp. 766-768
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ASSOCIATED WITH INDUCTION TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - A RANDOMIZED TRIAL BY THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER LEUKEMIA COOPERATIVE GROUP
Authors: ZITTOUN R SUCIU S MANDELLI F DEWITTE T THALER J STRYCKMANS P HAYAT M PEETERMANS M CADIOU M SOLBU G PETTI MC WILLEMZE R
Citation: R. Zittoun et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ASSOCIATED WITH INDUCTION TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - A RANDOMIZED TRIAL BY THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER LEUKEMIA COOPERATIVE GROUP, Journal of clinical oncology, 14(7), 1996, pp. 2150-2159
Risultati: 1-25 | 26-50 | 51-55